BNP Paribas Financial Markets
HZNP

BNP Paribas Financial Markets’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BNP Paribas Financial Markets’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-98,385
Closed -$11.4M – 4154
2023
Q3 		$11.4M Sell
98,385
-55,346
-36% -$5.95M 0.01% 847
2023
Q2 		$15.8M Sell
153,731
-149,245
-49% -$15.7M 0.02% 721
2023
Q1 		$33.1M Buy
302,976
+140,124
+86% +$15.5M 0.05% 415
2022
Q4 		$18.5M Sell
162,852
-21,912
-12% -$1.82M 0.03% 691
2022
Q3 		$11.4M Buy
184,764
+38,505
+26% +$2.69M 0.02% 916
2022
Q2 		$11.7M Sell
146,259
-17,733
-11% -$1.68M 0.02% 831
2022
Q1 		$17.3M Sell
163,992
-40,275
-20% -$3.92M 0.02% 673
2021
Q4 		$22M Buy
204,267
+162,831
+393% +$17.8M 0.03% 613
2021
Q3 		$4.54M Sell
41,436
-12,224
-23% -$1.27M 0.01% 1358
2021
Q2 		$5.02M Sell
53,660
-640,365
-92% -$58.9M 0.01% 1285
2021
Q1 		$63.9M Buy
694,025
+631,184
+1,004% +$53.3M 0.09% 233
2020
Q4 		$4.6M Buy
62,841
+57,819
+1,151% +$4.3M 0.01% 1188
2020
Q3 		$390K Sell
5,022
-110,702
-96% -$7.62M ﹤0.01% 2367
2020
Q2 		$6.43M Sell
115,724
-36,080
-24% -$1.54M 0.01% 926
2020
Q1 		$4.5M Buy
151,804
+102,109
+205% +$3.45M 0.01% 1031
2019
Q4 		$1.8M Buy
49,695
+4,128
+9% +$127K ﹤0.01% 1728
2019
Q3 		$1.24M Sell
45,567
-32,838
-42% -$849K ﹤0.01% 1742
2019
Q2 		$1.89M Sell
78,405
-54,636
-41% -$1.39M ﹤0.01% 1477
2019
Q1 		$3.52M Buy
133,041
+63,484
+91% +$1.5M 0.01% 1140
2018
Q4 		$1.36M Sell
69,557
-8,681
-11% -$170K ﹤0.01% 1474
2018
Q3 		$1.53M Buy
78,238
+42,681
+120% +$811K ﹤0.01% 1593
2018
Q2 		$589K Buy
35,557
+934
+3% +$14.2K ﹤0.01% 1937
2018
Q1 		$492K Buy
34,623
+462
+1% +$6.83K ﹤0.01% 2222
2017
Q4 		$499K Sell
34,161
-9,915
-22% -$139K ﹤0.01% 2475
2017
Q3 		$559K Sell
44,076
-5,912
-12% -$75.2K ﹤0.01% 1928
2017
Q2 		$593K Buy
49,988
+40,591
+432% +$505K ﹤0.01% 1822
2017
Q1 		$139K Sell
9,397
-4,912
-34% -$79.6K ﹤0.01% 2376
2016
Q4 		$232K Sell
14,309
-1,035
-7% -$18.8K ﹤0.01% 2123
2016
Q3 		$278K Sell
15,344
-34,877
-69% -$681K ﹤0.01% 1563
2016
Q2 		$827K Sell
50,221
-55,389
-52% -$896K ﹤0.01% 1269
2016
Q1 		$1.75M Sell
105,610
-182
-0.2% -$3.18K 0.01% 868
2015
Q4 		$2.29M Buy
105,792
+42,256
+67% +$823K 0.01% 876
2015
Q3 		$1.26M Sell
63,536
-93,024
-59% -$2.94M ﹤0.01% 979
2015
Q2 		$5.44M Buy
156,560
+144,517
+1,200% +$4.41M 0.02% 566
2015
Q1 		$313K Buy
12,043
+4,543
+61% +$83.3K ﹤0.01% 1434
2014
Q4 		$96.7K Buy
+7,500
New +$93.9K ﹤0.01% 1520
2014
Q3 		– Sell
-9,065
Closed -$143K – 4373
2014
Q2 		$143K Sell
9,065
-3,346
-27% -$47.8K ﹤0.01% 1901
2014
Q1 		$176K Buy
12,411
+11,420
+1,152% +$129K ﹤0.01% 1832
2013
Q4 		$7.55K Sell
991
-13,778
-93% -$74.3K ﹤0.01% 2828
2013
Q3 		$49.5K Sell
14,769
-4,056
-22% -$10.7K ﹤0.01% 2512
2013
Q2 		$46.3K Buy
+18,825
New +$45.2K ﹤0.01% 2683

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BNP Paribas Financial Markets's HZNP Position: Q4 2023 in Review

BNP Paribas Financial Markets sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 98,385 shares — an estimated $11.4M sold.

BNP Paribas Financial Markets first reported a position in HZNP in Q2 2013 and held it in 41 quarters. The position peaked at $63.9M in Q1 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • BNP Paribas Financial Markets reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 98,385 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $11.4M.
  • BNP Paribas Financial Markets first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 41 quarters.
  • BNP Paribas Financial Markets's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $63.9M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2023, filed 7 Feb 2024.